Medytox Inc., 10% Owner at Evolus, Inc. (EOLS), bought 51,000 shares at $10.93 ($557K) on 2021-08-27, disclosed to the SEC on 2021-08-31.
Open-market purchase of $557k EOLS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| EOLS | BUY | 2023-02-06 | $565K | — | Filing → |
| EOLS | SELL | 2023-02-06 | $818K | — | Filing → |
| EOLS | SELL | 2022-10-07 | $689K | — | Filing → |